Together, these developments signal the beginning of a transformative era in MASH treatment, where patients may soon benefit from a diverse portfolio of targeted therapies designed to halt or even reverse disease progression
Nausea, vomiting, diarrhea, constipation, headaches, and abdominal pain are some of the more common side effects of the medication
In summary, GLP-1 drug manufacturing blends biotech fermenters and high-end peptide synthesis labs , requiring large capital projects, stringent quality control, and sophisticated purification
Discontinuation should be reserved for cases where heart rate changes are clearly problematic and alternative therapies are available
Secondary endpoints will be evaluated during a 32-week follow-up visit (105)